166 related articles for article (PubMed ID: 11486242)
1. Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial.
Sanderson JE; Haines CJ; Yeung L; Yip GW; Tang K; Yim SF; Jorgensen LN; Woo J
J Cardiovasc Pharmacol; 2001 Sep; 38(3):372-83. PubMed ID: 11486242
[TBL] [Abstract][Full Text] [Related]
2. The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris.
Haines CJ; Yim SF; Sanderson JE
Atherosclerosis; 2001 Dec; 159(2):467-70. PubMed ID: 11730828
[TBL] [Abstract][Full Text] [Related]
3. The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study.
Walker RJ; Lewis-Barned NJ; Sutherland WH; Goulding A; Edwards EA; de Jong SA; Gold E; Walker HL
Menopause; 2001; 8(1):27-32. PubMed ID: 11201511
[TBL] [Abstract][Full Text] [Related]
4. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
6. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
7. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
Stevenson JC; Oladipo A; Manassiev N; Whitehead MI; Guilford S; Proudler AJ
Br J Haematol; 2004 Mar; 124(6):802-8. PubMed ID: 15009069
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function.
Teede HJ; Liang YL; Kotsopoulos D; Zoungas S; Cravent R; McGrath BP
Clin Endocrinol (Oxf); 2001 Nov; 55(5):673-82. PubMed ID: 11894980
[TBL] [Abstract][Full Text] [Related]
10. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
11. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
[TBL] [Abstract][Full Text] [Related]
12. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Davidson MH; Maki KC; Marx P; Maki AC; Cyrowski MS; Nanavati N; Arce JC
Arch Intern Med; 2000 Nov; 160(21):3315-25. PubMed ID: 11088095
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
Alexandersen P; Riis BJ; Stakkestad JA; Delmas PD; Christiansen C
J Clin Endocrinol Metab; 2001 Feb; 86(2):755-60. PubMed ID: 11158042
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.
Salobir BG; Keber I; Vrabic L
Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
[TBL] [Abstract][Full Text] [Related]
17. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
18. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
Campagnoli C; Colombo P; De Aloysio D; Gambacciani M; Grazioli I; Nappi C; Serra GB; Genazzani AR
Maturitas; 2002 Apr; 41(4):299-311. PubMed ID: 12034517
[TBL] [Abstract][Full Text] [Related]
19. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
20. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
Lundström E; Christow A; Kersemaekers W; Svane G; Azavedo E; Söderqvist G; Mol-Arts M; Barkfeldt J; von Schoultz B
Am J Obstet Gynecol; 2002 Apr; 186(4):717-22. PubMed ID: 11967497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
